Abstract
In this observational, retrospective study, we performed economic analyses between
robotic arm-assisted total knee arthroplasty (RATKA) and manual total knee arthroplasty
(MTKA). Specifically, we compared: (1) index costs including computed tomography (CT)
scans; (2) 90-day postoperative health care utilization, (3) 90-day episode-of-care
(EOC) costs, and (4) lengths of stay between CT scan-based robotically-assisted versus
MTKAs. A large national database, Blue Health Intelligence (BHI), was used for RATKAs
and MTKAs performed between April 1, 2017 and September 30, 2019. Based on strict
inclusion–exclusion criteria, with propensity score matching, 4,135 RATKAs and 4,135
MTKAs were identified and analyzed. Index costs to the payer for RATKA patients were
found to be less than those for MTKA patients ($29,984 vs. $31,280, p <0.0001). Overall, 90-day EOC costs for RATKA patients were found to be less than
that for MTKA patients in the inpatient and outpatient settings. This also holds true
for the use of skilled nursing facilities, pharmacies, or other services. In conclusion,
the results from our study show that RATKA were associated with lower costs than MTKAs,
even when including the cost of CT scans. These results are of marked importance given
the emphasis to contain and reduce health care costs.
Keywords
episode-of-care - computed tomography scans - robotic-arm assisted manual - total
knee arthroplasty
